div class=trans-pagebuttonPage 1button div class=trans-image amp-img class=trans-thumb alt=Page 1: formular · Afectiune cardio-vasculara semnificativä Tratament cu antagoni§ti ai receptorilor de androgeni inhibitor de 5ct NU NU NU C DAO NU reductazä estrogen sau chimioterapie src=https:reader030fdocumentecomreader030viewer20220405115e5ba9b23876ed519b36a5c4html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 2button div class=trans-image amp-img class=trans-thumb alt=Page 2: formular · Afectiune cardio-vasculara semnificativä Tratament cu antagoni§ti ai receptorilor de androgeni inhibitor de 5ct NU NU NU C DAO NU reductazä estrogen sau chimioterapie src=https:reader030fdocumentecomreader030viewer20220405115e5ba9b23876ed519b36a5c4html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=trans-pagebuttonPage 3button div class=trans-image amp-img class=trans-thumb alt=Page 3: formular · Afectiune cardio-vasculara semnificativä Tratament cu antagoni§ti ai receptorilor de androgeni inhibitor de 5ct NU NU NU C DAO NU reductazä estrogen sau chimioterapie src=https:reader030fdocumentecomreader030viewer20220405115e5ba9b23876ed519b36a5c4html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdiv